brain diseases

It has been reported that reactive astrocytes and the monoamine oxidase B (MAO-B) enzyme within these cells can be utilised as therapeutic targets for AD.

Rutgers researchers have discovered some of the first molecular insights into how toxic proteins are regulated in neurodegenerative diseases.